NCT07590895

Brief Summary

The main objective of the study is to assess whether a dietary regimen based on the principles of the FODMAP diet, compared with the current treatment programme which does not include specific dietary recommendations, can improve pain symptoms in patients with symptomatic endometriosis and intestinal symptoms (i.e. bloating, nausea, constipation, diarrhoea and vomiting) attributable to irritable bowel syndrome, compared with a control group

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Mar 2024Dec 2026

Study Start

First participant enrolled

March 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2024

Completed
2 years until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

May 15, 2026

Status Verified

April 1, 2026

Enrollment Period

2.7 years

First QC Date

May 10, 2024

Last Update Submit

May 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of pain related syntomps in patients with bowel symptoms

    The primary objective of the study is to evaluate whether a dietary regimen based on the principles of the FODMAP diet versus the current treatment program, which does not include specific dietary indications, can change algic symptoms in patients with symptomatic endometriosis and the presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, compared with a control group. The outcome will be measured trough Numerical Rating Scale (NRS) on dismenorrea, dyspareunia, non menstrual pelvic pain and dyschezia.

    6 months

Secondary Outcomes (1)

  • Gastrointestinal syntomps, patient satisfaction, health-related quality of life, psychological conditions, patient's overall condition and anthropometric parameters

    6 months

Study Arms (2)

FODMAP diet group

EXPERIMENTAL

Patients randomized to the treatment arm were proposed to follow a FODMAP diet throughout the study period

Behavioral: FODMAP diet

Usual diet group

NO INTERVENTION

Interventions

FODMAP dietBEHAVIORAL

Diet low in oligosaccharides, disaccharides, monosaccharides and fermentable polyols

FODMAP diet group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 45 years
  • BMI between 18.5 and 24.9,
  • Surgical, clinical or instrumental diagnosis of endometriosis
  • Presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, on estro-progestin or progestin treatment or in the absence of hormonal treatment

You may not qualify if:

  • Associated conditions that may cause pelvic pain independent of the presence of endometriosis (e.g., pelvic varices and salpingitis outcomes)
  • chronic inflammatory bowel disease (Crohn's disease or ulcerative rectocolitis).
  • patients with obstructive uropathy, subocclusive intestinal stenosis
  • complex adnexal masses or typical endometriomas greater than 5 cm in diameter.
  • women who are obese (BMI ≥ 30) or underweight (BMI \< 18)
  • women on vegetarian-vegan dietary regimens,
  • women with metabolic diseases that require specific dietary indications such as in the case of diabetes and celiac disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Milan, 20122, Italy

RECRUITING

MeSH Terms

Conditions

Endometriosis

Interventions

FODMAP Diet

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Elimination DietsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 15, 2026

Study Start

March 1, 2024

Primary Completion (Estimated)

November 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

May 15, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations